Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis

The in vitro activity of tavaborole, an FDA-approved antifungal drug, was compared to that of four antifungal agents against 170 clinical fungal isolates originating from patients with onychomycosis. Tavaborole had low activity against all isolates compared to itraconazole, terbinafine, and fluconaz...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Abastabar, Mahdi, Haghani, Iman, Shokohi, Tahereh, Hedayati, Mohammad Taghi, Aghili, Seyed Reza, Jedi, Ali, Dadashi, Sulmaz, Shabanzadeh, Shafigheh, Hosseini, Tahereh, Aslani, Narges, Meis, Jacques F., Badali, Hamid
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2018
Matèries:
Susceptibility
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6256807/
https://ncbi.nlm.nih.gov/pubmed/30224524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01632-18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars